SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Mallinckrodt Pharmaceuticals plc
An SI Board Since April 2014
Posts SubjectMarks Bans Symbol
1 1 0 MNK
Emcee:  Carey Thompson Type:  Moderated
Introduction Market Data Compact
Mallinckrodt plc was incorporated in Ireland on January 9, 2013 for the purpose of holding the Pharmaceuticals business of Covidien plc ("Covidien"). On June 28, 2013, Covidien shareholders of record received one ordinary
share of Mallinckrodt for every eight ordinary shares of Covidien held as of the record date, June 19, 2013,
and the Pharmaceuticals business of Covidien was transferred to Mallinckrodt plc, thereby completing the legal
separation from Covidien ("the Separation"). On July 1, 2013, Mallinckrodt plc began regular trading on the
New York Stock Exchange under the ticker symbol "MNK."

This is spinoff from Covidien I received recently. Any information on MNK is encouraged.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2022 Knight Sac Media.  Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News